{"componentChunkName":"component---src-templates-topic-topic-tsx","path":"/topics/poisoning-or-overdose/","result":{"data":{"firstChapter":{"id":"fd8c261c-01ed-5610-bde0-8d80500e7c37","slug":"summary","fullItemName":"Summary","subChapters":[],"depth":1,"htmlHeader":"<!-- begin field 4dcd2d86-7151-48ed-b4d5-2ce4576bef9a --><h1>Poisoning or overdose: Summary</h1><!-- end field 4dcd2d86-7151-48ed-b4d5-2ce4576bef9a -->","htmlStringContent":"<!-- begin item 234268f1-c9c3-44c0-8737-5ea0bbe09aaf --><!-- begin field 388a8604-871f-44d8-8d9f-9c4d5c263861 --><ul><li>Poisoning denotes exposure to a substance that is dangerous to health or life. A poison may be a drug, household product, industrial chemical, or plant or animal derivative. </li><li>Poisoning may be accidental or deliberate.</li><li>Overdose is the use of a quantity of drug in excess of its intended or prescribed dose. It may be accidental or deliberate and involve the use of prescribed or illicit drugs.</li><li>In the UK, paracetamol is the medication most commonly used in cases of deliberate overdose. </li><li>Around 170,000 people are admitted hospital in the UK each year with suspected poisoning. </li><li>Prognosis depends on the type of poison, the quantity taken, and associated comorbidity.</li><li>Assessment involves assessing the person's level of consciousness, breathing and circulation; taking a history and performing an examination.</li><li>The history should include:<ul><li>Why was the substance taken?</li><li>What substance(s) were taken?</li><li>When was it taken?</li></ul></li><li>Examination may include:<ul><li>General observations.</li><li>Checking for signs consistent with the substance(s) taken.</li></ul></li><li>If the person has deliberately self-poisoned, assessment should include the risk of psychological harm and the risk of further self-harm or suicide; and any safeguarding concerns.</li><li>The following cases should be urgently referred to hospital:<ul><li>All children and young people who have deliberately self-poisoned.</li><li>Adults who have deliberately self-poisoned.</li><li>People who are symptomatic.</li><li>People who have taken poisons with a delayed action. These include aspirin, iron, paracetamol, tricyclic antidepressants, co-phenotrope and all modified-release preparations.</li><li>Where the type of poison is unknown.</li></ul></li><li>If a person refuses to go to hospital, the reasons why should be determined, and information about the potential consequences of not receiving hospital treatment provided.</li><li>If the person still refuses admission, and this is felt to be in their best interests, their capacity should be assessed and it should be considered whether a compulsory admission under the Mental Health Act is appropriate.<ul><li>If a person is judged to have diminished capacity and/or the presence of a significant mental health disorder, they should be referred for urgent hospital admission or urgent mental health assessment, depending on clinical judgement. </li><li>In emergency situations, the person's capacity should be assessed. It will almost always be in the person's best interests to give urgent treatment without delay.</li></ul></li><li>Admission to hospital is not usually indicated for accidental poisoning with agents of low toxicity.<ul><li>The person should be advised about expected adverse effects, and when to seek further medical advice. </li></ul></li><li>Hospital assessment is not usually indicated if a person has accidentally taken an additional tablet of their own medication. The indications, adverse effects and interactions of the medicine, the person's age, past medical history, medication and social circumstances should be considered. Advice should be sought where appropriate.</li></ul><!-- end field 388a8604-871f-44d8-8d9f-9c4d5c263861 --><!-- end item 234268f1-c9c3-44c0-8737-5ea0bbe09aaf -->","topic":{"id":"35a9353c-780d-5888-b05d-86650e852d6e","topicId":"94eca2fa-634d-4fe4-97af-372492295e17","topicName":"Poisoning or overdose","slug":"poisoning-or-overdose","aliases":[],"chapters":[{"id":"fd8c261c-01ed-5610-bde0-8d80500e7c37","slug":"summary","fullItemName":"Summary","subChapters":[]},{"id":"ab031f66-f43b-5ca2-a974-4d57cd3f46d6","slug":"have-i-got-the-right-topic","fullItemName":"Have I got the right topic?","subChapters":[]},{"id":"ffafe309-e0db-5e65-a7a3-fad084107042","slug":"how-up-to-date-is-this-topic","fullItemName":"How up-to-date is this topic?","subChapters":[{"id":"d72b8e4f-20c4-5cdc-b158-f3a116f8f63b","slug":"changes","fullItemName":"Changes"},{"id":"3af95292-5377-556e-b656-f4445a8f07a5","slug":"update","fullItemName":"Update"}]},{"id":"45919048-a26c-5310-a5eb-a3c00dc9101e","slug":"goals-outcome-measures","fullItemName":"Goals and outcome measures","subChapters":[{"id":"dcd0644d-5f1b-504a-b607-534ef46d1c2f","slug":"goals","fullItemName":"Goals"},{"id":"d089557e-7ca4-53c5-891f-17dd4b82988b","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"93b82eea-382d-50bc-9584-6095ff36e295","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"15f66839-61db-56fc-abce-3c6b229f76b2","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"b21d2dfd-e8ec-51f2-9341-0a47dd3ff141","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"0fd3222c-135e-5f07-89bb-91eda567209d","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"2781b105-c6d2-592a-ba95-d98522d77bd8","slug":"background-information","fullItemName":"Background information","subChapters":[{"id":"7c1289d8-46d7-5584-b003-a55f4cde5c40","slug":"definition","fullItemName":"Definition"},{"id":"ef5c3421-612c-54d4-97df-30eed579052b","slug":"causes","fullItemName":"Causes"},{"id":"c31c300d-cf26-56db-b9f2-484b53b4e083","slug":"prevalence","fullItemName":"Prevalence"},{"id":"709e5fcd-addf-54b4-a14a-982c63783075","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"6cbbe34a-839a-5bdb-ba47-fa2685f18ccc","slug":"diagnosis","fullItemName":"Diagnosis","subChapters":[{"id":"3ec573e4-3cfd-5646-b381-65ee43f2ebe8","slug":"presentation","fullItemName":"Presentation"},{"id":"e8b53a44-6e24-5d51-8eec-b21cd9818736","slug":"symptoms-signs-of-drugs-that-are-commonly-involved-in-poisoning-or-overdose","fullItemName":"Symptoms and signs of drugs that are commonly involved in poisoning or overdose"}]},{"id":"b30ea7cb-60ec-5f89-9547-6adca0ab5f63","slug":"management","fullItemName":"Management","subChapters":[{"id":"82eca93c-792b-5d2c-92af-034c960d0d72","slug":"management","fullItemName":"Scenario: Management"}]},{"id":"a65a50ac-11c4-5db5-a1e2-d9dc5a1f59fe","slug":"supporting-evidence","fullItemName":"Supporting evidence","subChapters":[]},{"id":"45c99b55-beff-5027-8a26-cb3a6f585dc9","slug":"how-this-topic-was-developed","fullItemName":"How this topic was developed","subChapters":[{"id":"2131bc03-ef5f-5186-b949-40f071c1487c","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"767a455f-db5d-506f-8f74-85bd0a62d130","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"63a43d1d-d327-521c-88c0-e9405d1fa840","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"ff8728c0-beff-5b2c-966e-265b3ef54500","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"3f40c970-c50c-509e-8b70-a539bf01bc9b","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"72f563f8-af72-5833-9203-4ea2b3f085d4","slug":"references","fullItemName":"References","subChapters":[]}]}},"topic":{"id":"35a9353c-780d-5888-b05d-86650e852d6e","topicId":"94eca2fa-634d-4fe4-97af-372492295e17","topicName":"Poisoning or overdose","slug":"poisoning-or-overdose","aliases":[],"topicSummary":"Poisoning denotes exposure to a substance that is dangerous to health or life. This may be a drug, household product, industrial chemical, plant or animal product","lastRevised":"Last revised in June 2017","nextPlannedReviewBy":"2022-06-01T00:00:00+01:00","nextPlannedReviewByDateTime":"2022-05","nextPlannedReviewByDisplay":"May 2022","specialities":[{"id":"45db1917-4d65-58d8-af3d-568321e486ed","name":"Drugs and devices","slug":"drugs-devices"},{"id":"460cf76a-c057-55d8-a7ab-50fe9463f7da","name":"Mental health","slug":"mental-health"},{"id":"b2883a65-3d71-5333-bb7d-c6251b5f3ab5","name":"Poisoning","slug":"poisoning"}],"chapters":[{"id":"fd8c261c-01ed-5610-bde0-8d80500e7c37","slug":"summary","fullItemName":"Summary","subChapters":[]},{"id":"ab031f66-f43b-5ca2-a974-4d57cd3f46d6","slug":"have-i-got-the-right-topic","fullItemName":"Have I got the right topic?","subChapters":[]},{"id":"ffafe309-e0db-5e65-a7a3-fad084107042","slug":"how-up-to-date-is-this-topic","fullItemName":"How up-to-date is this topic?","subChapters":[{"id":"d72b8e4f-20c4-5cdc-b158-f3a116f8f63b","slug":"changes","fullItemName":"Changes"},{"id":"3af95292-5377-556e-b656-f4445a8f07a5","slug":"update","fullItemName":"Update"}]},{"id":"45919048-a26c-5310-a5eb-a3c00dc9101e","slug":"goals-outcome-measures","fullItemName":"Goals and outcome measures","subChapters":[{"id":"dcd0644d-5f1b-504a-b607-534ef46d1c2f","slug":"goals","fullItemName":"Goals"},{"id":"d089557e-7ca4-53c5-891f-17dd4b82988b","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"93b82eea-382d-50bc-9584-6095ff36e295","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"15f66839-61db-56fc-abce-3c6b229f76b2","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"b21d2dfd-e8ec-51f2-9341-0a47dd3ff141","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"0fd3222c-135e-5f07-89bb-91eda567209d","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"2781b105-c6d2-592a-ba95-d98522d77bd8","slug":"background-information","fullItemName":"Background information","subChapters":[{"id":"7c1289d8-46d7-5584-b003-a55f4cde5c40","slug":"definition","fullItemName":"Definition"},{"id":"ef5c3421-612c-54d4-97df-30eed579052b","slug":"causes","fullItemName":"Causes"},{"id":"c31c300d-cf26-56db-b9f2-484b53b4e083","slug":"prevalence","fullItemName":"Prevalence"},{"id":"709e5fcd-addf-54b4-a14a-982c63783075","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"6cbbe34a-839a-5bdb-ba47-fa2685f18ccc","slug":"diagnosis","fullItemName":"Diagnosis","subChapters":[{"id":"3ec573e4-3cfd-5646-b381-65ee43f2ebe8","slug":"presentation","fullItemName":"Presentation"},{"id":"e8b53a44-6e24-5d51-8eec-b21cd9818736","slug":"symptoms-signs-of-drugs-that-are-commonly-involved-in-poisoning-or-overdose","fullItemName":"Symptoms and signs of drugs that are commonly involved in poisoning or overdose"}]},{"id":"b30ea7cb-60ec-5f89-9547-6adca0ab5f63","slug":"management","fullItemName":"Management","subChapters":[{"id":"82eca93c-792b-5d2c-92af-034c960d0d72","slug":"management","fullItemName":"Scenario: Management"}]},{"id":"a65a50ac-11c4-5db5-a1e2-d9dc5a1f59fe","slug":"supporting-evidence","fullItemName":"Supporting evidence","subChapters":[]},{"id":"45c99b55-beff-5027-8a26-cb3a6f585dc9","slug":"how-this-topic-was-developed","fullItemName":"How this topic was developed","subChapters":[{"id":"2131bc03-ef5f-5186-b949-40f071c1487c","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"767a455f-db5d-506f-8f74-85bd0a62d130","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"63a43d1d-d327-521c-88c0-e9405d1fa840","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"ff8728c0-beff-5b2c-966e-265b3ef54500","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"3f40c970-c50c-509e-8b70-a539bf01bc9b","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"72f563f8-af72-5833-9203-4ea2b3f085d4","slug":"references","fullItemName":"References","subChapters":[]}]}},"pageContext":{"id":"35a9353c-780d-5888-b05d-86650e852d6e"}},"staticQueryHashes":["3666801979"]}